News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Arrowhead Pharmaceuticals, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Deals
Promising Hep B Drug Makes SoCal’s Arrowhead Pharma a Pretty Target for Gilead and Other Big Companies
April 15, 2016
·
2 min read
Deals
Novartis AG Unloads RNAi Portfolio to Arrowhead Research Corporation for $35 Million
March 5, 2015
·
3 min read
Deals
Arrowhead Research Corporation Soars on Rumor of Gilead Sciences, Inc.'s Interest
December 31, 2014
·
2 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Arrowhead Pharmaceuticals to Participate in Upcoming March 2026 Events
February 24, 2026
·
4 min read
Press Releases
Arrowhead Pharmaceuticals Reports Fiscal 2026 First Quarter Results
February 6, 2026
·
12 min read
Press Releases
Sarepta Therapeutics Announces Approval of Clinical Trial Application for SRP-1005, Its Investigational Treatment for Huntington’s Disease
February 5, 2026
·
5 min read
Press Releases
Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-DIMER-PA – the First Dual Functional RNAi Therapeutic for the Treatment of Mixed Hyperlipidemia
January 28, 2026
·
7 min read
Press Releases
Arrowhead Pharmaceuticals to Webcast Fiscal 2026 First Quarter Results
January 21, 2026
·
4 min read
Press Releases
Press Release: Myqorzo and Redemplo approved in China
January 16, 2026
·
8 min read
Press Releases
Arrowhead Pharmaceuticals Prices Upsized Offerings of Convertible Senior Notes, Common Stock and Pre-Funded Warrants
January 8, 2026
·
11 min read
Press Releases
Sarepta Therapeutics Announces Submission of Clinical Trial Application for SRP-1005, its Investigational Treatment for Huntington’s Disease
January 8, 2026
·
6 min read
Press Releases
Arrowhead Pharmaceuticals Announces NMPA Approval of REDEMPLO® (plozasiran) for Familial Chylomicronemia Syndrome (FCS) in China
January 7, 2026
·
7 min read
Press Releases
Arrowhead Pharmaceuticals Announces Proposed Offerings of Convertible Senior Notes and Common Stock
January 7, 2026
·
8 min read
